PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH
Authors:
- Aurélie S. LeroyerALAurélie S. Leroyer
- Zouher MajdZMZouher Majd
- Fanny LalloyerFLFanny Lalloyer
- Emmanuelle VallezEVEmmanuelle Vallez
- Kadiombo BantubungiKBKadiombo Bantubungi
- Giulia Chinetti-GbaguidiGCGiulia Chinetti-Gbaguidi
- Philippe DelerivePDPhilippe Delerive
- Chantal M. BoulangerCBChantal M. Boulanger
- Bart StaelsBSBart Staels
- Anne TailleuxATAnne Tailleux
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 218 (1) , 69-76
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cellsHepatology, 2010
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisThe Lancet, 2010
- Monocytes in atherosclerosis: subsets and functionsNature Reviews Cardiology, 2010
- Macrophage Apoptosis in Atherosclerosis: Consequences on Plaque Progression and the Role of Endoplasmic Reticulum StressAntioxidants & Redox Signaling, 2009
- Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic SyndromeThe American Journal of Pathology, 2008
- Pioglitazone Reduces Endothelial Microparticles in the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesJournal of Hepatology, 2006
- High levels of circulating endothelial microparticles in patients with acute coronary syndromesAmerican Heart Journal, 2003
- Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitusJournal of Human Hypertension, 2002
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998